GC1107

BIOLOGICAL2 trials

Sponsors

Green Cross Corporation

Conditions

Bacterial Infections

Phase 2

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children

CompletedNCT01402713

Green Cross CorporationBacterial Infections

Start: 2011-08-31End: 2013-11-30Updated: 2015-01-26

Phase 3

To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults

CompletedNCT02361866

Green Cross CorporationBacterial Infections

Start: 2014-05-31End: 2014-10-31Updated: 2015-02-12

Related Papers

A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults

Journal of Korean Medical Science2019-01-0111 citations